The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergetics

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 602-610

  Dinkova Kostova, Albena T ^a,b   Baird, Liam ^a,e   Holmström, Kira M ^c   Meyer, Colin J ^d   Abramov, Andrey Y ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Reata Pharmaceuticals Inc   (United States)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytoprotection; FRET FLIM; Mitochondria; PINK1; Redox

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; PINK1 PROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; KEAP1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; BIOENERGY; CELL PROTECTION; CONFORMATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; FATTY ACID OXIDATION; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; CHEMISTRY; ENERGY METABOLISM; MITOCHONDRION; MOLECULAR MODEL; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ENERGY METABOLISM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; MITOCHONDRIA; MODELS, MOLECULAR; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84938775013     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150003     Document Type: Article

References (59)

1. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D. and Yamamoto, M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86 CrossRef PubMed
2. Cullinan, S.B., Gordan, J.D., Jin, J., Harper, J.W. and Diehl, J.A. (2004) The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24, 8477-8486 CrossRef PubMed
3. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K. and Yamamoto, M. (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139 CrossRef PubMed
4. Zhang, D.D., Lo, S.C., Cross, J.V., Templeton, D.J. and Hannink, M. (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24, 10941-10953 CrossRef PubMed
5. Dinkova-Kostova, A.T., Holtzclaw, W.D., Cole, R.N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M. and Talalay, P. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99, 11908-11913 CrossRef PubMed
6. McMahon, M., Lamont, D.J., Beattie, K.A. and Hayes, J.D. (2010) Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. U.S.A. 107, 18838-18843 CrossRef PubMed
7. Kensler, T.W. and Wakabayashi, N. (2010) Nrf2: friend or foe for chemoprevention? Carcinogenesis 31, 90-99 CrossRef PubMed
8. Suzuki, T., Motohashi, H. and Yamamoto, M. (2013) Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol. Sci. 34, 340-346 CrossRef PubMed
9. Hayes, J.D. and Dinkova-Kostova, A.T. (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39, 199-218 CrossRef PubMed
10. Baird, L., Lleres, D., Swift, S. and Dinkova-Kostova, A.T. (2013) Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc. Natl. Acad. Sci. U.S.A. 110, 15259-15264 CrossRef PubMed
11. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. and Hayes, J.D. (2006) Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 281, 24756-24768 CrossRef PubMed
12. Tong, K.I., Kobayashi, A., Katsuoka, F. and Yamamoto, M. (2006) Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387, 1311-1320 CrossRef PubMed
13. Zhang, Y., Talalay, P., Cho, C.G. and Posner, G.H. (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U.S.A. 89, 2399-2403 CrossRef PubMed
14. Ahn, Y.H., Hwang, Y., Liu, H., Wang, X.J., Zhang, Y., Stephenson, K.K., Boronina, T.N., Cole, R.N., Dinkova-Kostova, A.T., Talalay, P. and Cole, P.A. (2010) Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc. Natl. Acad. Sci. U.S.A. 107, 9590-9595 CrossRef PubMed
15. Baird, L., Swift, S., Lleres, D. and Dinkova-Kostova, A.T. (2014) Monitoring Keap1-Nrf2 interactions in single live cells. Biotechnol. Adv. 32, 1133-1144 CrossRef PubMed
16. Dinkova-Kostova, A.T., Holtzclaw, W.D. and Wakabayashi, N. (2005) Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 44, 6889-6899 CrossRef PubMed
17. Eggler, A.L., Liu, G., Pezzuto, J.M., van Breemen, R.B. and Mesecar, A.D. (2005) Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. U.S.A. 102, 10070-10075 CrossRef PubMed
18. Li, Y., Paonessa, J.D. and Zhang, Y. (2012) Mechanism of chemical activation of Nrf2. PLoS One 7, e35122 CrossRef PubMed
19. Wild, A.C., Moinova, H.R. and Mulcahy, R.T. (1999) Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem. 274, 33627-33636 CrossRef PubMed
20. Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., Wang, H., Tamba, M., Itoh, K., Yamamoto, M. and Bannai, S. (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 277, 44765-44771 CrossRef PubMed
21. Singh, A., Rangasamy, T., Thimmulappa, R.K., Lee, H., Osburn, W.O., Brigelius-Flohe, R., Kensler, T.W., Yamamoto, M. and Biswal, S. (2006) Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am. J. Respir Cell Mol. Biol. 35, 639-650 CrossRef PubMed
22. Benedict, A.L., Knatko, E.V. and Dinkova-Kostova, A.T. (2012) The indirect antioxidant sulforaphane protects against thiopurine-mediated photooxidative stress. Carcinogenesis 33, 2457-2466 CrossRef PubMed
23. Holmstrom, K.M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J.M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A.T. and Abramov, A.Y. (2013) Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol. Open 2, 761-770 CrossRef PubMed
24. Gao, X., Dinkova-Kostova, A.T. and Talalay, P. (2001) Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. Proc. Natl. Acad. Sci. U.S.A. 98, 15221-15226 CrossRef PubMed
25. Kalra, S., Knatko, E.V., Zhang, Y., Honda, T., Yamamoto, M. and Dinkova-Kostova, A.T. (2012) Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone): implications for protection against UV radiation during thiopurine therapy. Cancer Prev. Res. 5, 973-981 CrossRef
26. Hawkes, H.J., Karlenius, T.C. and Tonissen, K.F. (2014) Regulation of the human thioredoxin gene promoter and its key substrates: a study of functional and putative regulatory elements. Biochim. Biophys. Acta 1840, 303-314 CrossRef PubMed
27. Sakurai, A., Nishimoto, M., Himeno, S., Imura, N., Tsujimoto, M., Kunimoto, M. and Hara, S. (2005) Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. J. Cell Physiol. 203, 529-537 CrossRef PubMed
28. Wakabayashi, N., Dinkova-Kostova, A.T., Holtzclaw, W.D., Kang, M.I., Kobayashi, A., Yamamoto, M., Kensler, T.W. and Talalay, P. (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U.S.A. 101, 2040-2045 CrossRef PubMed
29. Abbas, K., Breton, J., Planson, A.G., Bouton, C., Bignon, J., Seguin, C., Riquier, S., Toledano, M.B. and Drapier, J.C. (2011) Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages. Free Radic. Biol. Med. 51, 107-114 CrossRef PubMed
30. Thimmulappa, R.K., Mai, K.H., Srisuma, S., Kensler, T.W., Yamamoto, M. and Biswal, S. (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62, 5196-5203 PubMed
31. Lee, J.M., Calkins, M.J., Chan, K., Kan, Y.W. and Johnson, J.A. (2003) Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278, 12029-12038 CrossRef PubMed
32. Wu, K.C., Cui, J.Y. and Klaassen, C.D. (2011) Beneficial role of nrf2 in regulating NADPH generation and consumption. Toxicol. Sci. 123, 590-600 CrossRef PubMed
33. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M. and Motohashi, H. (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22, 66-79 CrossRef PubMed
34. Kovac, S., Angelova, P.R., Holmstrom, K.M., Zhang, Y., Dinkova-Kostova, A.T. and Abramov, A.Y. (2015) Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim. Biophys. Acta 1850, 794-801 CrossRef PubMed
35. Piantadosi, C.A., Carraway, M.S., Babiker, A. and Suliman, H.B. (2008) Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res. 103, 1232-1240 CrossRef PubMed
36. MacGarvey, N.C., Suliman, H.B., Bartz, R.R., Fu, P., Withers, C.M., Welty-Wolf, K.E. and Piantadosi, C.A. (2012) Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med. 185, 851-861 CrossRef PubMed
37. Lo, S.C. and Hannink, M. (2008) PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Exp. Cell Res. 314, 1789-1803 CrossRef PubMed
38. Lo, S.C. and Hannink, M. (2006) PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J. Biol. Chem. 281, 37893-37903 CrossRef PubMed
39. Xu, Y., Fang, F., Miriyala, S., Crooks, P.A., Oberley, T.D., Chaiswing, L., Noel, T., Holley, A.K., Zhao, Y., Kiningham, K.K. et al. (2013) KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells. Cancer Res. 73, 4406-4417 CrossRef PubMed
40. Kim, T.H., Hur, E.G., Kang, S.J., Kim, J.A., Thapa, D., Lee, Y.M., Ku, S.K., Jung, Y. and Kwak, M.K. (2011) NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Cancer Res. 71, 2260-2275 CrossRef PubMed
41. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I. et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322 CrossRef PubMed
42. Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D.R. et al. (2003) Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35, 238-245 CrossRef PubMed
43. Taguchi, K., Maher, J.M., Suzuki, T., Kawatani, Y., Motohashi, H. and Yamamoto, M. (2010) Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Mol. Cell. Biol. 30, 3016-3026 CrossRef PubMed
44. Higgins, L.G. and Hayes, J.D. (2011) The cap'n'collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics. Chem. Biol. Interact. 192, 37-45 CrossRef PubMed
45. Meakin, P.J., Chowdhry, S., Sharma, R.S., Ashford, F.B., Walsh, S.V., McCrimmon, R.J., Dinkova-Kostova, A.T., Dillon, J.F., Hayes, J.D. and Ashford, M.L. (2014) Susceptibility of Nrf2-null mice to Steatohepatitis and Cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol. Cell. Biol. 34, 3305-3320 CrossRef PubMed
46. Ludtmann, M.H., Angelova, P.R., Zhang, Y., Abramov, A.Y. and Dinkova-Kostova, A.T. (2014) Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem. J. 457, 415-424 CrossRef PubMed
47. Pang, S., Lynn, D.A., Lo, J.Y., Paek, J. and Curran, S.P. (2014) SKN-1 and Nrf2 couples proline catabolism with lipid metabolism during nutrient deprivation. Nat. Commun. 5, 5048 CrossRef PubMed
48. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160 CrossRef PubMed
49. Gandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D.S., Tabrizi, S.J., Wood, N.W. et al. (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol. Cell. 33, 627-638 CrossRef PubMed
50. Abramov, A.Y., Gegg, M., Grunewald, A., Wood, N.W., Klein, C. and Schapira, A.H. (2011) Bioenergetic consequences of PINK1 mutations in Parkinson disease. PLoS One 6, e25622 CrossRef PubMed
51. Gandhi, S., Vaarmann, A., Yao, Z., Duchen, M.R., Wood, N.W. and Abramov, A.Y. (2012) Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease. PLoS One 7, e37564 CrossRef PubMed
52. Reisman, S.A., Lee, C.Y., Meyer, C.J., Proksch, J.W. and Ward, K.W. (2014) Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin. Arch. Dermatol. Res. 306, 447-454 CrossRef PubMed
53. Burton, N.C., Kensler, T.W. and Guilarte, T.R. (2006) In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology 27, 1094-1100 CrossRef PubMed
54. Chen, P.C., Vargas, M.R., Pani, A.K., Smeyne, R.J., Johnson, D.A., Kan, Y.W. and Johnson, J.A. (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc. Natl. Acad. Sci. U.S.A. 106, 2933-2938 CrossRef PubMed
55. Innamorato, N.G., Jazwa, A., Rojo, A.I., Garcia, C., Fernandez-Ruiz, J., Grochot-Przeczek, A., Stachurska, A., Jozkowicz, A., Dulak, J. and Cuadrado, A. (2010) Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS One 5, e11838 CrossRef PubMed
56. Kaidery, N.A., Banerjee, R., Yang, L., Smirnova, N.A., Hushpulian, D.M., Liby, K.T., Williams, C.R., Yamamoto, M., Kensler, T.W., Ratan, R.R. et al. (2013) Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease. Antioxid. Redox Signal. 18, 139-157 CrossRef PubMed
57. Napoli, E., Wong, S., Hertz-Picciotto, I. and Giulivi, C. (2014) Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 133, e1405-1410 CrossRef PubMed
58. Singh, K., Connors, S.L., Macklin, E.A., Smith, K.D., Fahey, J.W., Talalay, P. and Zimmerman, A.W. (2014) Sulforaphane treatment of autism spectrum disorder (ASD). Proc. Natl. Acad. Sci. U.S.A. 111, 15550-15555 CrossRef PubMed
59. Armah, C.N., Traka, M.H., Dainty, J.R., Defernez, M., Janssens, A., Leung, W., Doleman, J.F., Potter, J.F. and Mithen, R.F. (2013) A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function. Am. J. Clin. Nutr. 98, 712-722 CrossRef PubMed